A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics

Amit Lakhanpal; Ernest Brahn

doi:10.5152/eurjrheum.2020.2065

Short Communication

A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics

Volume 7 · Issue 2 Publish Date: May 22, 2020

Amit Lakhanpal Ernest Brahn

Full Text

DOI

Published In

European Journal of Rheumatology

Volume 7 · Issue 2

Pages: S102-S106

History

Published Online: May 22, 2020

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright © 2020 European Journal of Rheumatology

Amit Lakhanpal

Division of Rheumatology, Hospital for Special Surgery, New York, NY, USA

Ernest Brahn

Division of Rheumatology, UCLA School of Medicine, Los Angeles, CA, USA

Lakhanpal, A., & Brahn, E. (2020). A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics. European Journal of Rheumatology, 7(2), S102-S106. https://doi.org/10.5152/eurjrheum.2020.2065

Endnote/Zotero/Mendeley (RIS) BibTeX

Full Text

Full Text PDF

Abstract

Cite this article as: Lakhanpal A, Brahn E. A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics. Eur J Rheumatol 2020; 7(Suppl 2): S102-6.

Similar Articles

Article Info

Published In

Journal European Journal of Rheumatology

Volume / Issue Volume 7 · Issue 2

Pages S102-S106

DOI 10.5152/eurjrheum.2020.2065

History

Published Online May 22, 2020

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright

Affiliations

Amit Lakhanpal

Division of Rheumatology, Hospital for Special Surgery, New York, NY, USA

Ernest Brahn

Division of Rheumatology, UCLA School of Medicine, Los Angeles, CA, USA

Cite this Article

Lakhanpal, A., & Brahn, E. (2020). A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics. European Journal of Rheumatology, 7(2), S102-S106. https://doi.org/10.5152/eurjrheum.2020.2065

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Outlines